MURRAYS MEDICAL UK LTD

Company Registration Number:
11420103 (England and Wales)

Unaudited abridged accounts for the year ended 31 May 2024

Period of accounts

Start date: 01 June 2023

End date: 31 May 2024

MURRAYS MEDICAL UK LTD

Contents of the Financial Statements

for the Period Ended 31 May 2024

Balance sheet
Notes

MURRAYS MEDICAL UK LTD

Balance sheet

As at 31 May 2024


Notes

2024

2023


£

£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets:   0 0
Tangible assets: 3 10,139 15,011
Investments:   0 0
Total fixed assets: 10,139 15,011
Current assets
Stocks: 77,493 31,217
Debtors:   149,866 113,476
Cash at bank and in hand: 17,513 14,201
Investments:   0 0
Total current assets: 244,872 158,894
Creditors: amounts falling due within one year:   (170,258) (101,816)
Net current assets (liabilities): 74,614 57,078
Total assets less current liabilities: 84,753 72,089
Creditors: amounts falling due after more than one year:   0 0
Provision for liabilities: 0 0
Total net assets (liabilities): 84,753 72,089
Capital and reserves
Called up share capital: 100 100
Share premium account: 0 0
Revaluation reserve: 00
Other reserves: 0 0
Profit and loss account: 84,653 71,989
Shareholders funds: 84,753 72,089

The notes form part of these financial statements

MURRAYS MEDICAL UK LTD

Balance sheet statements

For the year ending 31 May 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 17 December 2024
and signed on behalf of the board by:

Name: ROBERT MURRAY
Status: Director

The notes form part of these financial statements

MURRAYS MEDICAL UK LTD

Notes to the Financial Statements

for the Period Ended 31 May 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

MURRAYS MEDICAL UK LTD

Notes to the Financial Statements

for the Period Ended 31 May 2024

2. Employees

2024 2023
Average number of employees during the period 2 2

MURRAYS MEDICAL UK LTD

Notes to the Financial Statements

for the Period Ended 31 May 2024

3. Tangible Assets

Total
Cost £
At 01 June 2023 24,346
Additions 0
Disposals 0
Revaluations 0
Transfers 0
At 31 May 2024 24,346
Depreciation
At 01 June 2023 9,335
Charge for year 4,872
On disposals 0
Other adjustments 0
At 31 May 2024 14,207
Net book value
At 31 May 2024 10,139
At 31 May 2023 15,011

MURRAYS MEDICAL UK LTD

Notes to the Financial Statements

for the Period Ended 31 May 2024

4. Related party transactions

Name of the related party:
Relationship:
Parent
Description of the Transaction: At the year end there was a balance owed to Murray's Medical Equipment Limited of £12,251 Dr (2023 - £66,331).
£
Balance at 01 June 2023 0
Balance at 31 May 2024 12,251

MURRAYS MEDICAL UK LTD

Notes to the Financial Statements

for the Period Ended 31 May 2024

5. Post balance sheet events

There were no post balance sheet events which require disclosure.